Risk factors | Total n = 40 | Complications | CCI 0/1 (p value) | Median CCI (IQR) 22.6 (0.0–42.6) | CCI 0–100 (p value) | |
---|---|---|---|---|---|---|
No (n = 12) (30%) | Yes (n = 28) (70%) | |||||
Age (mean ± SD) | 91.6 (± 1.5) | 91.1 (± 1.2) | 91.8 (± 1.6) | 0.110 | – | 0.014b |
Gender | ||||||
Man | 13 (32%) | 3 (25.0%) | 10 (35.7%) | 0.507 | 22.6 (4.4–77.5) | 0.391 |
Woman | 27 (68%) | 9 (75.0%) | 18 (64.7%) | 22.6 (0.0–36.2) | ||
ASA | ||||||
I–II III–IV | 8 (20%) 32 (80%) | 3 (25.0%) 9 (75.0%) | 5 (17.9%) 23 (82.1%) | 0.605 | 15.7 (0.0–39.2) 23.4 (0.0–43.7) | 0.475 |
S-MPM | ||||||
I | 5 (13%) | 2 (16.7%) | 3 (10.7%) | 0.673 | 22.6 (0.0–61.3) | 0.390 |
II | 27 (67%) | 8 (66.7%) | 19 (67.9%) | 22.6 (0.0–32.0) | ||
III | 8 (20%) | 2 (16.7%) | 6 (21.4%) | 45.6 (2.2–89.7) | ||
Charlson Comorbidity Index | ||||||
No | 8 (20%) | 2 (5.0%) | 6 (21.4%) | 0.631 | 33.7 (2.2–56.7) | 0.698 |
Low | 11 (28%) | 5 (41.7%) | 6 (21.4%) | 8.7 (0.0–100) | ||
HIgh | 21 (52%) | 5 (41.7%) | 16 (57.1%) | 22.6 (6.1–34.1) | ||
Neoplasm location | ||||||
Right sidea | 23 (58%) | 3 (25.0%) | 20 (71.4%) | 0.006 | 30.0 (20.9–50.7) | 0.015 |
Left side | 17 (42%) | 9 (75.0%) | 8 (28.6%) | 0.0 (0.0–26.7) | ||
Type of surgery | ||||||
elective | 24 (60%) | 7 (58.3%) | 17 (60.7%) | 0.919 | 22.6 (0.0–31.7) | 0.576 |
emergency | 16 (40%) | 5 (41.7%) | 11 (39.3%) | 23.4 (0.0–57.8) | ||
Intent of surgery | 0.002 | |||||
Curative | 34 (85%) | 7 (58.3%) | 27 (96.4%) | 0.006 | 27.5 (8.7–47.3) | |
Palliative | 6 (15%) | 5 (41.7%) | 1 (3.6%) | 0.0 (0.0–3.1) | ||
Anastomosis | ||||||
No | 18 (45%) | 8 (66.7%) | 10 (35.7%) | 0.070 | 10.5 (0.0–40.9) | 0.325 |
Yes | 22 (55%) | 4 (33.3%) | 18 (64.3%) | 23.4 (17.9–45.1) | ||
Transfusion | ||||||
No | 21 (53%) | 12 (100.0%) | 9 (32.1%) | < 0.001 | 0.0 (0.0–21.8) | < 0.001 |
Yes | 19 (47%) | 0 (0.0%) | 19 (67.9%) | 32.0 (24.2–54.9) | ||
TNM stage | ||||||
I–II | 28 (70%) | 8 (66.7%) | 20 (71.4%) | 0.763 | 22.6 (0.0–36.2) | 0.493 |
III–IV | 12 (30%) | 4 (33.3%) | 8 (28.6%) | 26.7 (0.0–88.7) |